Research programme: TIE-2 receptor agonists - Aerpio Pharmaceuticals

Drug Profile

Research programme: TIE-2 receptor agonists - Aerpio Pharmaceuticals

Alternative Names: AKB 9785

Latest Information Update: 21 Mar 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Aerpio Therapeutics
  • Developer Aerpio Pharmaceuticals
  • Class Antibacterials; Small molecules
  • Mechanism of Action TIE-2 receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Preclinical Bacterial infections

Most Recent Events

  • 15 Mar 2017 Zeta Acquisition Corp II in a reverse merger transaction acquires Aerpio Therapeutics and changes its name to Aerpio Pharmaceuticals
  • 13 May 2016 Preclinical trials in Bacterial infections in USA (unspecified route)
  • 13 May 2016 Pharmacodynamics data from a preclinical study in bacterial infections presented at the 112th International Conference of the American Thoracic Society (ATC-2016)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top